Guidelines for Therapeutic Interchange—2004
نویسندگان
چکیده
منابع مشابه
Guidelines for therapeutic interchange-2004.
This publication is an update of the American College of Clinical Pharmacy (ACCP) Position Statement on “Guidelines for Therapeutic Interchange,” originally published in 1993. The ACCP supports the practice of therapeutic interchange, in which pharmacists collaborate with physicians and other health care professionals to develop policies and implement programs that improve drug use to provide t...
متن کاملEthical Guidelines for Internal Audit Reporting Lines
The present study identifies ethical ways of auditing reporting, which define the relationship between internal audit and the various authorities of the organization. Defining these lines as determinants of impartiality and independence of internal audit is of great importance. In this research, the structural equation model has been used to test the proposed model. The information required for...
متن کاملGuidelines for Therapeutic Drug Monitoring of Vancomycin: A Systematic Review
BACKGROUND AND OBJECTIVE Despite the availability of clinical practice guidelines (CPGs) for therapeutic drug monitoring (TDM) of vancomycin, vancomycin serum concentrations still do not reach therapeutic concentrations in many patients. Thus, we sought to systematically review the quality and consistency of recommendations for an international cohort of CPGs regarding vancomycin TDM. METHODS...
متن کاملHLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
In HLH-94, the first prospective international treatment study for hemophagocytic lymphohistiocytosis (HLH), diagnosis was based on five criteria (fever, splenomegaly, bicytopenia, hypertriglyceridemia and/or hypofibrinogenemia, and hemophagocytosis). In HLH-2004 three additional criteria are introduced; low/absent NK-cell-activity, hyperferritinemia, and high-soluble interleukin-2-receptor lev...
متن کاملHepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.
Western and Eastern perspectives on therapeutic guidelines for hepatocellular carcinoma (HCC) have many commonalities but may also differ in certain aspects, as described in this article. In view of the limited therapeutic options for advanced HCC, evidence-based therapies are few, and thus there is a dependence on consensus-based guidelines. This article focuses on the Italian Association for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacotherapy
سال: 2005
ISSN: 0277-0008
DOI: 10.1592/phco.2005.25.11.1666